SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-21-042819
Filing Date
2021-03-29
Accepted
2021-03-29 09:01:00
Documents
12
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm2110271d1_10k.htm 10-K 1260027
2 EXHIBIT 4.5 tm2110271d1_ex4-5.htm EX-4.5 34054
3 EXHIBIT 21.1 tm2110271d1_ex21-1.htm EX-21.1 1329
4 EXHIBIT 31.1 tm2110271d1_ex31-1.htm EX-31.1 10025
5 EXHIBIT 32.1 tm2110271d1_ex32-1.htm EX-32.1 4958
6 GRAPHIC tm2110271d1_10kimg001.jpg GRAPHIC 62969
7 GRAPHIC tm2110271d1_10kimage01.jpg GRAPHIC 32519
8 GRAPHIC tm2110271d1_10kimage02.jpg GRAPHIC 40894
9 GRAPHIC tm2110271d1_10kimage03.jpg GRAPHIC 22785
10 GRAPHIC tm2110271d1_10kimage04.jpg GRAPHIC 19134
11 GRAPHIC tm2110271d1_10kimage05.jpg GRAPHIC 20820
12 GRAPHIC tm2110271d1_10kimage06.jpg GRAPHIC 33100
  Complete submission text file 0001104659-21-042819.txt   1632380
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40034 | Film No.: 21779669
SIC: 2834 Pharmaceutical Preparations